DR. RECKEWEG R13 Prohaemorrhin

Product NDC: 53346-1313
11-digit product format: 533461313
Labeler code: 53346
Product ID: 53346-1313_e002f75e-45f8-4b61-8772-0c3d10627e80
Type: HUMAN OTC DRUG
Nonproprietary name: Aesculus hippocastanum 2X, Collinsonia canadensis 4X, Graphites 8X, Hamamelis virginiana 3X, Kali carbonicum 6X, Lycopodium clavatum 5X, Nitricum acidum 6X, Nux vomica 4X, Paeonia officinalis 3X, Sulphur 5X
Dosage form: LIQUID
Route: ORAL
Labeler: PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start: 1986-06-01
Marketing end: 0000-00-00
Substance: HORSE CHESTNUT; COLLINSONIA CANADENSIS ROOT; GRAPHITE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; POTASSIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; STRYCHNOS NUX-VOMICA SEED; PAEONIA OFFICINALIS ROOT; SULFUR
Active strength: 2 [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	53346-1313		I	Inactivated by FDA		2026-10-05
excluded package	package	53346-1313	53346-1313-5	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53346-1313-5	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53346-1313-5	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53346-1313-5	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53346-1313-5	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53346-1313-5	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53346-1313-5	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53346-1313-5	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53346-1313-5	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53346-1313-5	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	53346-1313-5	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	53346-1313-5	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	53346-1313-5	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	53346-1313-5	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	53346-1313-5	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	53346-1313-5	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	53346-1313-5	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	53346-1313-5	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	53346-1313-5	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	53346-1313-5	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53346-1313-5	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53346-1313-5	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	53346-1313-5	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
53346-1313-5	2020-01-31	C162847	48780-1	9d75b9d0-88f0-f424-e053-dadaa90a57ce	DR. RECKEWEG R13 Prohämorrhin

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53346-1313-5	DR. RECKEWEG R13 ProhaemorrhinCombination Product	50 mL in 1 BOTTLE	LIQUID	50		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
COLLINSONIA CANADENSIS ROOT	ACTIVE INGREDIENT	O2630F3XDR	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
GRAPHITE	ACTIVE INGREDIENT	4QQN74LH4O	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	ACTIVE INGREDIENT	T7S323PKJS	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
HORSE CHESTNUT	ACTIVE INGREDIENT	3C18L6RJAZ	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
LYCOPODIUM CLAVATUM SPORE	ACTIVE INGREDIENT	C88X29Y479	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
NITRIC ACID	ACTIVE INGREDIENT	411VRN1TV4	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
PAEONIA OFFICINALIS ROOT	ACTIVE INGREDIENT	8R564U2E1P	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
POTASSIUM CARBONATE	ACTIVE INGREDIENT	BQN1B9B9HA	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
STRYCHNOS NUX-VOMICA SEED	ACTIVE INGREDIENT	269XH13919	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
SULFUR	ACTIVE INGREDIENT	70FD1KFU70	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
CARBONATE ION	ACTIVE MOIETY	7UJQ5OPE7D	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
COLLINSONIA CANADENSIS ROOT	ACTIVE MOIETY	O2630F3XDR	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
GRAPHITE	ACTIVE MOIETY	4QQN74LH4O	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	ACTIVE MOIETY	T7S323PKJS	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
HORSE CHESTNUT	ACTIVE MOIETY	3C18L6RJAZ	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
LYCOPODIUM CLAVATUM SPORE	ACTIVE MOIETY	C88X29Y479	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
NITRIC ACID	ACTIVE MOIETY	411VRN1TV4	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
PAEONIA OFFICINALIS ROOT	ACTIVE MOIETY	8R564U2E1P	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
STRYCHNOS NUX-VOMICA SEED	ACTIVE MOIETY	269XH13919	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
SULFUR	ACTIVE MOIETY	70FD1KFU70	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53346-1313	DR. RECKEWEG R13 PROHAEMORRHIN COMBINATION PRODUCT (AESCULUS HIPPOCASTANUM 2X, COLLINSONIA CANADENSIS 4X, GRAPHITES 8X, HAMAMELIS VIRGINIANA 3X, KALI CARBONICUM 6X, LYCOPODIUM CLAVATUM 5X, NITRICUM ACIDUM 6X, NUX VOMICA 4X, PAEONIA OFFICINALIS 3X, SULPHUR 5X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1	Legacy NDC, 1 package rows	20130514_b294800f-b158-49aa-86d6-1ba769385076.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3C18L6RJAZ	HORSE CHESTNUT		HORSE CHESTNUT
O2630F3XDR	COLLINSONIA CANADENSIS ROOT		COLLINSONIA CANADENSIS ROOT
4QQN74LH4O	GRAPHITE	7782-42-5	GRAPHITE
T7S323PKJS	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK		HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK
BQN1B9B9HA	POTASSIUM CARBONATE	584-08-7	POTASSIUM CARBONATE
C88X29Y479	LYCOPODIUM CLAVATUM SPORE	8023-70-9	LYCOPODIUM CLAVATUM SPORE
411VRN1TV4	NITRIC ACID	7697-37-2	NITRIC ACID
269XH13919	STRYCHNOS NUX-VOMICA SEED	8046-97-7	STRYCHNOS NUX-VOMICA SEED
8R564U2E1P	PAEONIA OFFICINALIS ROOT		PAEONIA OFFICINALIS ROOT
70FD1KFU70	SULFUR	7704-34-9	SULFUR

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
53346-1313-5	53346131305	50 mL in 1 BOTTLE	50 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
DR. RECKEWEG R13 Prohämorrhin	PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO	2013-04-03	HUMAN OTC DRUG LABEL	1